Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Highly Affordable Lab Safety Shield

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Provides protection for chemists from draughts, splashes, aerosols and spills.

Asynt's Lab Safety Shield has been designed to neatly fit around popular brands of stirrer hotplate to provide protection for chemists from draughts, splashes, aerosols and spills.

Ideal for use where fumehood space is at a premium, the compact and highly affordable Asynt Lab Safety Shield provides additional protection to chemists undertaking applications such as heated parallel reactions in tubes.

The device also beneficially shields reactions from the cooling effect of fumehood ventilation, particularly important when consistent and reproducible heating to parallel experiments is required.

Manufactured from robust 5mm polycarbonate, the Lab Safety Shield is resistant to a wide range of laboratory solvents and is temperature-resistant to 170°C.

Designed with a small footprint (29.5 x 16 x 17cm) to minimize use of valuable fumehood space, the shield maintains access to hotplate controls and gives good all-round visibility of the reaction or process.

Manufactured in the UK, this is the only compact safety shield available for under £100 which fits Asynt, IKA and Heidolph stirrer hotplates.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Asynt DrySyn™ Reaches Out to Aspiring Chemists
Newcastle University’s new Outreach project, which aims to inspire young people to gain interest in chemistry, uses Asynt DrySyn heating blocks.
Thursday, June 24, 2010
A Treasure Trove for the Synthetic Chemist
Asynt’s website offers solutions for synthesis, purification, and evaporation as well as an extensive library of molecular building blocks.
Friday, May 11, 2007
Asynt Announce UK Distribution for the Vapourtec V-10
Versatile V-10 offers extensive flexibility and enables rapid, low temperature evaporation of compounds.
Wednesday, November 30, 2005
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos